Review of the experiences from the first childhood influenza vaccination programme with a live attenuated influenza vaccine in England and Scotland
In 2012, the Joint Committee on Vaccination and Immunisation recommended that the National Immunisation Programme for influenza be extended to include healthy children/adolescents aged 2-17 years. In the UK, extension of this new immunisation programme began in 2013-2014 and targeted children aged 2...
Gespeichert in:
Veröffentlicht in: | Drugs in Context 2015-05, Vol.4, p.212280-9 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 9 |
---|---|
container_issue | |
container_start_page | 212280 |
container_title | Drugs in Context |
container_volume | 4 |
creator | Kassianos, George White, Sharon Reynolds, Arlene J Rajaram, Sankarasubramanian |
description | In 2012, the Joint Committee on Vaccination and Immunisation recommended that the National Immunisation Programme for influenza be extended to include healthy children/adolescents aged 2-17 years. In the UK, extension of this new immunisation programme began in 2013-2014 and targeted children aged 2 years and 3 years in primary care. Several implementation pilots were undertaken in primary schools across England, Scotland, Wales and Northern Ireland, as well as a single pilot in a secondary school in England. This article shares lessons learnt from experiences in England and Scotland to provide guidance for other countries considering the addition of childhood influenza vaccination into their national immunisation programmes. Recommendations are provided to help ensure effective preparation and management of new childhood influenza vaccination programmes in other countries. This article describes the processes utilised in England and Scotland for programme setup, workforce management, identification and care of contraindicated patients, collection of data on vaccine uptake, communication strategies, and education of parents and children. |
doi_str_mv | 10.7573/dic.212280 |
format | Article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4423484</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_0c8cc682d5ae40698280a05218f69227</doaj_id><sourcerecordid>1681258968</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3590-fe5a016d5772780fde6904c064c6bbfae9fa0230d43178bd03d041cc818fe59d3</originalsourceid><addsrcrecordid>eNplkt9uFCEUxidGY2v1xgcwXBqTqcAAAzcmpmm1SRMT_1wTFs7s0MzACsy29jV8Ydnd2th4QeB8fOcHOfma5jXBpz3vu_fO21NKKJX4SXNMeoZb1in5dH_mLVGSHDUvcr7GmHEsxPPmiHLVU4X5cfP7K2w93KA4oDICgtsNJA_BQkZDivNeHHzKBdnRT26M0SEfhmmBcGfQ1ljrgyk-BrRJcZ3MPAO68WVEBk1-C8iUAmExBf5vg6qg87CeTHBot77ZWHbFy-bZYKYMr-73k-bHxfn3s8_t1ZdPl2cfr1rbcYXbAbjBRDje97SXeHAgFGYWC2bFajUYUIPBtMOOdaSXK4c7hxmxVhJZW5XrTprLA9dFc603yc8m_dLReL0XYlprk4q3E2hspbVCUscNMCyUrMM2mNOKEorSvrI-HFibZTWDsxBKMtMj6OOb4Ee9jlvNGO2YZBXw9h6Q4s8FctGzzxamOhCIS9ZESEK5VEJW67uD1aaYc4Lh4RmC9S4RuiZCHxJRzW_-_diD9W8Euj8KL7Sd</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1681258968</pqid></control><display><type>article</type><title>Review of the experiences from the first childhood influenza vaccination programme with a live attenuated influenza vaccine in England and Scotland</title><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Kassianos, George ; White, Sharon ; Reynolds, Arlene J ; Rajaram, Sankarasubramanian</creator><creatorcontrib>Kassianos, George ; White, Sharon ; Reynolds, Arlene J ; Rajaram, Sankarasubramanian</creatorcontrib><description>In 2012, the Joint Committee on Vaccination and Immunisation recommended that the National Immunisation Programme for influenza be extended to include healthy children/adolescents aged 2-17 years. In the UK, extension of this new immunisation programme began in 2013-2014 and targeted children aged 2 years and 3 years in primary care. Several implementation pilots were undertaken in primary schools across England, Scotland, Wales and Northern Ireland, as well as a single pilot in a secondary school in England. This article shares lessons learnt from experiences in England and Scotland to provide guidance for other countries considering the addition of childhood influenza vaccination into their national immunisation programmes. Recommendations are provided to help ensure effective preparation and management of new childhood influenza vaccination programmes in other countries. This article describes the processes utilised in England and Scotland for programme setup, workforce management, identification and care of contraindicated patients, collection of data on vaccine uptake, communication strategies, and education of parents and children.</description><identifier>ISSN: 1745-1981</identifier><identifier>ISSN: 1740-4398</identifier><identifier>EISSN: 1740-4398</identifier><identifier>DOI: 10.7573/dic.212280</identifier><identifier>PMID: 25972905</identifier><language>eng</language><publisher>England: Just Medical Media Limited</publisher><subject>children ; England ; Improving Practice ; influenza ; pilot project ; schools ; Scotland ; vaccination ; vaccine</subject><ispartof>Drugs in Context, 2015-05, Vol.4, p.212280-9</ispartof><rights>Copyright © 2015 Kassianos G, White S, Reynolds AJ, Rajaram S. 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3590-fe5a016d5772780fde6904c064c6bbfae9fa0230d43178bd03d041cc818fe59d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423484/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423484/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,861,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25972905$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kassianos, George</creatorcontrib><creatorcontrib>White, Sharon</creatorcontrib><creatorcontrib>Reynolds, Arlene J</creatorcontrib><creatorcontrib>Rajaram, Sankarasubramanian</creatorcontrib><title>Review of the experiences from the first childhood influenza vaccination programme with a live attenuated influenza vaccine in England and Scotland</title><title>Drugs in Context</title><addtitle>Drugs Context</addtitle><description>In 2012, the Joint Committee on Vaccination and Immunisation recommended that the National Immunisation Programme for influenza be extended to include healthy children/adolescents aged 2-17 years. In the UK, extension of this new immunisation programme began in 2013-2014 and targeted children aged 2 years and 3 years in primary care. Several implementation pilots were undertaken in primary schools across England, Scotland, Wales and Northern Ireland, as well as a single pilot in a secondary school in England. This article shares lessons learnt from experiences in England and Scotland to provide guidance for other countries considering the addition of childhood influenza vaccination into their national immunisation programmes. Recommendations are provided to help ensure effective preparation and management of new childhood influenza vaccination programmes in other countries. This article describes the processes utilised in England and Scotland for programme setup, workforce management, identification and care of contraindicated patients, collection of data on vaccine uptake, communication strategies, and education of parents and children.</description><subject>children</subject><subject>England</subject><subject>Improving Practice</subject><subject>influenza</subject><subject>pilot project</subject><subject>schools</subject><subject>Scotland</subject><subject>vaccination</subject><subject>vaccine</subject><issn>1745-1981</issn><issn>1740-4398</issn><issn>1740-4398</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNplkt9uFCEUxidGY2v1xgcwXBqTqcAAAzcmpmm1SRMT_1wTFs7s0MzACsy29jV8Ydnd2th4QeB8fOcHOfma5jXBpz3vu_fO21NKKJX4SXNMeoZb1in5dH_mLVGSHDUvcr7GmHEsxPPmiHLVU4X5cfP7K2w93KA4oDICgtsNJA_BQkZDivNeHHzKBdnRT26M0SEfhmmBcGfQ1ljrgyk-BrRJcZ3MPAO68WVEBk1-C8iUAmExBf5vg6qg87CeTHBot77ZWHbFy-bZYKYMr-73k-bHxfn3s8_t1ZdPl2cfr1rbcYXbAbjBRDje97SXeHAgFGYWC2bFajUYUIPBtMOOdaSXK4c7hxmxVhJZW5XrTprLA9dFc603yc8m_dLReL0XYlprk4q3E2hspbVCUscNMCyUrMM2mNOKEorSvrI-HFibZTWDsxBKMtMj6OOb4Ee9jlvNGO2YZBXw9h6Q4s8FctGzzxamOhCIS9ZESEK5VEJW67uD1aaYc4Lh4RmC9S4RuiZCHxJRzW_-_diD9W8Euj8KL7Sd</recordid><startdate>20150501</startdate><enddate>20150501</enddate><creator>Kassianos, George</creator><creator>White, Sharon</creator><creator>Reynolds, Arlene J</creator><creator>Rajaram, Sankarasubramanian</creator><general>Just Medical Media Limited</general><general>BioExcel Publishing Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20150501</creationdate><title>Review of the experiences from the first childhood influenza vaccination programme with a live attenuated influenza vaccine in England and Scotland</title><author>Kassianos, George ; White, Sharon ; Reynolds, Arlene J ; Rajaram, Sankarasubramanian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3590-fe5a016d5772780fde6904c064c6bbfae9fa0230d43178bd03d041cc818fe59d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>children</topic><topic>England</topic><topic>Improving Practice</topic><topic>influenza</topic><topic>pilot project</topic><topic>schools</topic><topic>Scotland</topic><topic>vaccination</topic><topic>vaccine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kassianos, George</creatorcontrib><creatorcontrib>White, Sharon</creatorcontrib><creatorcontrib>Reynolds, Arlene J</creatorcontrib><creatorcontrib>Rajaram, Sankarasubramanian</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Drugs in Context</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kassianos, George</au><au>White, Sharon</au><au>Reynolds, Arlene J</au><au>Rajaram, Sankarasubramanian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Review of the experiences from the first childhood influenza vaccination programme with a live attenuated influenza vaccine in England and Scotland</atitle><jtitle>Drugs in Context</jtitle><addtitle>Drugs Context</addtitle><date>2015-05-01</date><risdate>2015</risdate><volume>4</volume><spage>212280</spage><epage>9</epage><pages>212280-9</pages><issn>1745-1981</issn><issn>1740-4398</issn><eissn>1740-4398</eissn><abstract>In 2012, the Joint Committee on Vaccination and Immunisation recommended that the National Immunisation Programme for influenza be extended to include healthy children/adolescents aged 2-17 years. In the UK, extension of this new immunisation programme began in 2013-2014 and targeted children aged 2 years and 3 years in primary care. Several implementation pilots were undertaken in primary schools across England, Scotland, Wales and Northern Ireland, as well as a single pilot in a secondary school in England. This article shares lessons learnt from experiences in England and Scotland to provide guidance for other countries considering the addition of childhood influenza vaccination into their national immunisation programmes. Recommendations are provided to help ensure effective preparation and management of new childhood influenza vaccination programmes in other countries. This article describes the processes utilised in England and Scotland for programme setup, workforce management, identification and care of contraindicated patients, collection of data on vaccine uptake, communication strategies, and education of parents and children.</abstract><cop>England</cop><pub>Just Medical Media Limited</pub><pmid>25972905</pmid><doi>10.7573/dic.212280</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1745-1981 |
ispartof | Drugs in Context, 2015-05, Vol.4, p.212280-9 |
issn | 1745-1981 1740-4398 1740-4398 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4423484 |
source | DOAJ Directory of Open Access Journals; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | children England Improving Practice influenza pilot project schools Scotland vaccination vaccine |
title | Review of the experiences from the first childhood influenza vaccination programme with a live attenuated influenza vaccine in England and Scotland |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T01%3A05%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Review%20of%20the%20experiences%20from%20the%20first%20childhood%20influenza%20vaccination%20programme%20with%20a%20live%20attenuated%20influenza%20vaccine%20in%20England%20and%20Scotland&rft.jtitle=Drugs%20in%20Context&rft.au=Kassianos,%20George&rft.date=2015-05-01&rft.volume=4&rft.spage=212280&rft.epage=9&rft.pages=212280-9&rft.issn=1745-1981&rft.eissn=1740-4398&rft_id=info:doi/10.7573/dic.212280&rft_dat=%3Cproquest_doaj_%3E1681258968%3C/proquest_doaj_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1681258968&rft_id=info:pmid/25972905&rft_doaj_id=oai_doaj_org_article_0c8cc682d5ae40698280a05218f69227&rfr_iscdi=true |